Antibiotic Drug Resistance 2019
DOI: 10.1002/9781119282549.ch6
|View full text |Cite
|
Sign up to set email alerts
|

Impact of Key and Secondary Drug Resistance Mutations on Structure and Activity of β‐Lactamases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 47 publications
0
2
0
Order By: Relevance
“…The TEM-type βL family is characterized by a high degree of mutability (~30% of amino acid residues were found to mutate). Some of the mutations affect the substrate specificity, enzyme activity, and thermal stability [16,17]. At the same time, the Ω-loop is a highly conserved region (Figure 7).…”
Section: The Effect Of Mutations In ω-Loop Residues On Properties Of mentioning
confidence: 99%
See 1 more Smart Citation
“…The TEM-type βL family is characterized by a high degree of mutability (~30% of amino acid residues were found to mutate). Some of the mutations affect the substrate specificity, enzyme activity, and thermal stability [16,17]. At the same time, the Ω-loop is a highly conserved region (Figure 7).…”
Section: The Effect Of Mutations In ω-Loop Residues On Properties Of mentioning
confidence: 99%
“…The Ω-loop is located at the bottom of the entrance to the enzyme active site and includes the catalytically important and highly conserved residue Glu166, the mutation of which leads to an almost complete loss of enzyme activity. This review focuses on the structural peculiarities of the Ω-loop of TEM-type βLs-the most versatile group of serine class A enzymes that still remain one of the most common βLs among bacterial clinical pathogens and soil bacteria [16,17]. A detailed analysis of the loop is carried out in order to establish its role as a site of the allosteric regulation of activity and the specificity of βLs, as well as a potential target for novel inhibitors.…”
mentioning
confidence: 99%